The National Cancer Institute Division of Cancer Control and Population Science hosted a virtual conference on the Future of Cancer Health Economics Research and included a presentation from a workgroup that considered current challenges and future directions in health economics research centered on cancer treatment. The workgroup identified 3 broad categories of focus: data limitations, opportunities for training for clinicians and health economists interested in collaboration, and the need for prospective economic study of cancer treatment. Within these areas of focus, the workgroup recommended the following: improvement of the availability of key economic measures in data available to researchers, creation of more comprehensive datasets robust to insurance type or coverage, development of cancer care health economics research-focused symposia, instituting clear mechanisms to support integration of economic analyses alongside clinical trials, development of standardized methods to measure the cost of cancer care to health-care systems and patients, and development of standardized evaluations that include measures of social determinants of health.
CITATION STYLE
Yu, J. B., Schrag, D., & Robin Yabroff, K. (2022). Health Economics Research in Cancer Treatment: Current Challenges and Future Directions. Journal of the National Cancer Institute - Monographs, 2022(59), 51–56. https://doi.org/10.1093/jncimonographs/lgac009
Mendeley helps you to discover research relevant for your work.